Sandoz Cefpodoxime 100 mg, 40 mg/ 5 mL Film-coated tablets and Powder for suspension
PDF Leaflet Revision Date: 28 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of upper and lower respiratory tract infections.
Dosage (summary)
Adults: 100 mg every 12 hours; 200 mg every 12 hours for severe infections. Adjust for renal impairment.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy and lactation.
Key Drug Interactions
- Antacids decrease absorption
- Probenecid increases serum levels
- Increased bleeding risk with anticoagulants
Contraindications
- Hypersensitivity to cephalosporins
- Children with phenylketonuria
- Children under 1 year
Common side effects
- Nausea
- Headache
- Skin rashes
- Diarrhoea
Counselling Points
- Take with food
- Monitor for allergic reactions
- Report severe skin reactions immediately
Serious warnings
- Serious hypersensitivity reactions
- Risk of Clostridium difficile infection
- Severe cutaneous adverse reactions
Important Disclaimer
The Sandoz Cefpodoxime 100 mg, 40 mg/ 5 mL Film-coated tablets and Powder for suspension professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
